What are the treatment options for syphilis and chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Syphilis and Chlamydia

Syphilis Treatment

Primary and Secondary Syphilis (Early Syphilis)

Benzathine penicillin G 2.4 million units intramuscularly as a single dose is the definitive treatment for primary and secondary syphilis. 1, 2

  • This regimen has over 40 years of proven clinical effectiveness in achieving local cure, healing lesions, preventing sexual transmission, and preventing late sequelae 3
  • The same single-dose regimen applies regardless of HIV status 3, 1

Latent Syphilis

For early latent syphilis (acquired within the past year), give benzathine penicillin G 2.4 million units IM as a single dose. 1, 4

For late latent syphilis or syphilis of unknown duration, give benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units). 1, 4

  • Early latent syphilis is defined by documented seroconversion, unequivocal symptoms of primary or secondary syphilis within the past year, or a sex partner with documented early syphilis 4
  • All other cases should be treated as late latent syphilis 3, 4

Alternative Regimens for Penicillin Allergy (Non-Pregnant Patients)

Doxycycline 100 mg orally twice daily for 14 days is the preferred alternative for penicillin-allergic patients with primary, secondary, or early latent syphilis. 1, 5, 6

  • For late latent syphilis in penicillin-allergic patients, extend doxycycline to 100 mg orally twice daily for 28 days 4, 5, 6
  • Doxycycline is preferred over tetracycline due to better compliance with twice-daily versus four-times-daily dosing 1, 5
  • Tetracycline 500 mg orally four times daily for 14 days (early) or 28 days (late latent) is an acceptable alternative but less practical 1, 4
  • Ceftriaxone 1 g daily (IM or IV) for 8-10 days may be considered, though optimal dosing is not well established 1

Critical caveat: Pregnant patients with penicillin allergy must be desensitized and treated with penicillin—there are no acceptable alternatives in pregnancy. 4, 5

Special Considerations

HIV Co-infection

  • HIV-infected patients receive the same penicillin regimens as HIV-negative patients 3, 1
  • However, closer follow-up is required: every 3 months instead of every 6 months 1, 5
  • For late latent syphilis in HIV-infected patients, perform CSF examination before treatment to exclude neurosyphilis 3, 4

Pre-Treatment Evaluation for Latent Syphilis

  • Perform lumbar puncture before treatment if any of the following are present: neurologic or ophthalmic signs/symptoms, evidence of active tertiary syphilis, treatment failure, HIV infection with late latent syphilis, or nontreponemal titer ≥1:32 (unless duration <1 year is documented) 4
  • If CSF shows neurosyphilis, treat with aqueous crystalline penicillin G 18-24 million units IV daily for 10-14 days instead 4

Follow-Up Protocol

  • Perform clinical and serologic evaluation at 6 and 12 months after treatment for early syphilis 3, 1
  • For latent syphilis, repeat quantitative nontreponemal tests at 6,12, and 24 months 4, 5
  • Treatment failure is defined by: persistent or recurring signs/symptoms, sustained fourfold increase in nontreponemal titers, or failure of initially high titers to decline fourfold within 6-12 months 3, 1, 4
  • HIV-infected patients require more frequent monitoring at 3-month intervals 1, 5

Common Pitfalls

  • Jarisch-Herxheimer reaction (fever, headache, myalgia) may occur within 24 hours after treatment, especially in early syphilis—this is expected and does not indicate treatment failure 1
  • Macrolide resistance in T. pallidum is widespread in the United States, making azithromycin unsuitable despite some historical evidence of efficacy 1
  • Serologic tests may decline more slowly in patients with previous syphilis infections 3, 1
  • Benzathine penicillin G shortages have occurred; when unavailable, doxycycline can be initiated while actively searching for penicillin 7

Chlamydia Treatment

Note: The provided evidence does not contain specific guidelines or recommendations for chlamydia treatment. Based on standard medical knowledge and the brief mention in the evidence:

Standard Treatment (General Medical Knowledge)

Doxycycline 100 mg orally twice daily for 7 days is the first-line treatment for uncomplicated chlamydial infections. 6

  • The FDA label for doxycycline specifies this regimen for uncomplicated urethral, endocervical, or rectal infection caused by Chlamydia trachomatis 6
  • Alternative: Azithromycin 1 g orally as a single dose (though doxycycline is preferred due to higher efficacy)

Special Populations

  • Pregnant patients: Azithromycin 1 g orally as a single dose is preferred (doxycycline is contraindicated in pregnancy)
  • Nongonococcal urethritis (NGU) caused by C. trachomatis: Doxycycline 100 mg orally twice daily for 7 days 6

Follow-Up

  • Test of cure is recommended 3-4 weeks after treatment completion in pregnant patients
  • Retest all patients 3 months after treatment due to high reinfection rates
  • Treat sexual partners from the past 60 days

References

Guideline

Treatment for Acute Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Latent Stage Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Syphilis in Non-Pregnant Individuals Allergic to Penicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.